Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients - The PIPAC-OPC3 CC Trial

NCT03280511 is registered in ClinicalTrials.gov with Michael Bau Mortensen as lead sponsor.

NCT NCT03280511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03280511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients - The PIPAC-OPC3 CC Trial
Lead sponsor
Michael Bau Mortensen
Phase
Phase 2
Overall status
Recruiting
Start date
December 14, 2017
Completion date
March 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer, peritoneal carcinomatosis, peritoneal metastases, peritoneum cancer